IOBT
Closed
Io Biotech Inc
1.38
-0.01 (-0.72%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.39
Day's Range: 1.3 - 1.4396
Send
sign up or login to leave a comment!
When Written:
1.86
IO Biotech Inc is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark. The company is focused on developing novel immunotherapies for the treatment of cancer and infectious diseases. IO Biotech's lead product candidate, IO102, is a first-in-class immune modulatory molecule that has shown promising results in preclinical and early clinical studies. The company is also developing a pipeline of other immunotherapies that target various aspects of the immune system to enhance the body's ability to fight cancer and infectious diseases. IO Biotech has partnerships with several leading pharmaceutical companies and academic institutions to advance its research and development programs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








